Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2025 01:00 ET | Source: Pharming Group N.V.

Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow

Pharming Group reports Q3 2025 results with significant growth in revenue, profit, and cash flow driven by rare disease portfolio performance.
October 30, 2025 03:00 ET | Source: Pharming Group N.V.

Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London

Pharming CEO will participate in Fireside Chat on Nov. 19 at the Jefferies Global Healthcare Conference being held in London Nov. 17-20, 2025.
October 23, 2025 02:00 ET | Source: Pharming Group N.V.

Pharming Group to report third quarter 2025 financial results and provide business update on November 6

Pharming to report third quarter 2025 financial results and provide a business update on November 6, 2025, and host conference call at 13:30 CET/07:30 ET.
October 20, 2025 02:00 ET | Source: Pharming Group N.V.

Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio

Pharming announces 12 abstracts have been accepted for presentation at 2025 ACAAI Annual Scientific meeting being held in Orlando, Florida on November 6-10
October 06, 2025 11:35 ET | Source: Pharming Group N.V.

Pharming Group provides update on previously announced G&A expense reduction plan

Pharming provides update on previously announced G&A expense reduction plan
October 01, 2025 01:00 ET | Source: Pharming Group N.V.

Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years

Pharming sNDA for leniolisib in children aged 4-11 years with APDS accepted and granted Priority Review by FDA.
September 10, 2025 01:00 ET | Source: Pharming Group N.V.

Pharming Group promoted to the Euronext AMX® index

Leiden, the Netherlands, September 10, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that it has been promoted from the Euronext AScX® (Small...
September 03, 2025 02:00 ET | Source: Pharming Group N.V.

Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference

Leiden, the Netherlands, September 3, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the H.C. Wainwright 27th...
September 02, 2025 01:00 ET | Source: Pharming Group N.V.

Pharming Group appoints Kenneth Lynard as Chief Financial Officer

Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced the appointment of Kenneth Lynard as Chief Financial...
August 04, 2025 02:00 ET | Source: Pharming Group N.V.

Pharming Group to participate in August investor conference

Leiden, the Netherlands, August 4, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor...